Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 18, 2014BloodOpen Access

Clinical heterogeneity and predictors of outcome in primary autoimmune hemolytic anemia: a GIMEMA study of 308 patients

View Full Paper
Ask AI
Bookmark
Share

Authors

WBWilma BarcelliniBFBruno FattizzoAZAnna Zaninoni

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Barcellini et al. (2014) studied this question.

synapsesocial.com/papers/6a726cf75d37378ac1df3502https://doi.org/10.1182/blood-2014-06-583021
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Hematopoetic stem cell transplantation for immune thrombocytopenia and other refractory autoimmune cytopenias2008 · 41 citations
  2. 2Competing risks in epidemiology: possibilities and pitfalls2012 · 995 citations
  3. 3Low-dose rituximab in adult patients with idiopathic autoimmune hemolytic anemia: clinical efficacy and biologic studies2012 · 145 citations
  4. 4Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation2011 · 327 citations
  5. 5Rituximab in the treatment of autoimmune haematological disorders2008 · 205 citations